NEUROCRINE BIOSCIENCES, INC. (NBIX) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
NEUROCRINE BIOSCIENCES, INC. (NBIX) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current assets$1.64 BCurrent liabilities$874.50 MLiabilities$1.67 BAssets$5.36 BNon-current liabilities$791.00 MEquity$3.69 BNon-current assets$3.72 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivableCash and cash equivalentsPrepaid expensesInventoryAvailable-for-sale debt securitiesOther current assetsIntangible assets, netGoodwillRight-of-use assetsNoncurrent inventoryEquity investmentsNoncurrent available-for-sale debt securitiesProperty and equipment, netOther noncurrent assetsDeferred tax assetsAccounts payable and accrued liabilitiesOther current liabilitiesNoncurrent operating lease liabilitiesOther noncurrent liabilitiesDeferred tax liabilitiesAdditional paid-in capitalRetained earningsAccumulated other comprehensive incomeCommon stock, $0.001 par value; 220.0 shares authorized; 101.6 and 100.1 shares issued and outstanding, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityAccounts receivableAccounts receivable$887.00 MCurrent assetsCurrent assets$1.64 BCash and cash equivalentsCash and cash equivalents$332.40 MCurrent liabilitiesCurrent liabilities$874.50 MPrepaid expensesPrepaid expenses$217.10 MAccounts payable and accrued liabilitiesAccounts payable and accrued liabilities$808.30 MLiabilitiesLiabilities$1.67 BInventoryInventory$104.20 MOther current liabilitiesOther current liabilities$66.20 MAssetsAssets$5.36 BAvailable-for-sale debt securitiesAvailable-for-sale debt securities$57.40 MNon-current liabilitiesNon-current liabilities$791.00 MNoncurrent operating lease liabilitiesNoncurrent operating lease liabilities$401.80 MOther current assetsOther current assets$39.40 MOther noncurrent liabilitiesOther noncurrent liabilities$297.70 MDeferred tax liabilitiesDeferred tax liabilities$91.50 MEquityEquity$3.69 BIntangible assets, netIntangible assets, net$2.23 BNon-current assetsNon-current assets$3.72 BAdditional paid-in capitalAdditional paid-in capital$2.96 BGoodwillGoodwill$500.60 MRight-of-use assetsRight-of-use assets$448.00 MNoncurrent inventoryNoncurrent inventory$149.10 MRetained earningsRetained earnings$724.00 MEquity investmentsEquity investments$147.30 MAccumulated other comprehensive incomeAccumulated other comprehensive income$5.10 MNoncurrent available-for-sale debt securitiesNoncurrent available-for-sale debt securities$91.90 MCommon stock, $0.001 par value; 220.0 shares authorized; 101.6 and 100.1 shares issued and outstanding, respectivelyCommon stock$100.00 KProperty and equipment, netProperty and equipment, net$90.50 MOther noncurrent assetsOther noncurrent assets$59.30 MDeferred tax assetsDeferred tax assets$8.90 M
Chart details

NEUROCRINE BIOSCIENCES, INC. (NBIX) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
5,359,100,000 US dollars
Current assets
1,637,500,000 US dollars
Non-current assets
3,721,600,000 US dollars
Liabilities
1,665,500,000 US dollars
Current liabilities
874,500,000 US dollars
Non-current liabilities
791,000,000 US dollars
Equity
3,693,600,000 US dollars
Accounts receivable
887,000,000 US dollars
Cash and cash equivalents
332,400,000 US dollars
Prepaid expenses
217,100,000 US dollars
Inventory
104,200,000 US dollars
Available-for-sale debt securities
57,400,000 US dollars
Other current assets
39,400,000 US dollars
Intangible assets, net
2,226,000,000 US dollars
Goodwill
500,600,000 US dollars
Right-of-use assets
448,000,000 US dollars
Noncurrent inventory
149,100,000 US dollars
Equity investments
147,300,000 US dollars
Noncurrent available-for-sale debt securities
91,900,000 US dollars
Property and equipment, net
90,500,000 US dollars
Other noncurrent assets
59,300,000 US dollars
Deferred tax assets
8,900,000 US dollars
Accounts payable and accrued liabilities
808,300,000 US dollars
Other current liabilities
66,200,000 US dollars
Noncurrent operating lease liabilities
401,800,000 US dollars
Other noncurrent liabilities
297,700,000 US dollars
Deferred tax liabilities
91,500,000 US dollars
Additional paid-in capital
2,964,400,000 US dollars
Retained earnings
724,000,000 US dollars
Accumulated other comprehensive income
5,100,000 US dollars
Common stock, $0.001 par value; 220.0 shares authorized; 101.6 and 100.1 shares issued and outstanding, respectively
100,000 US dollars
Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding
0 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
NEUROCRINE BIOSCIENCES, INC. (NBIX) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!